冠昊生物 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	377.0M	404.0M	377.0M	489.0M	437.0M
Revenue Growth %	-6.7%	7.2%	-22.9%	11.9%	--
Total Revenue	377.0M	404.0M	377.0M	489.0M	437.0M
Cost Of Revenue	77.5M	84.4M	89.6M	122.0M	120.0M
+Gross Profit	299.5M	319.6M	287.4M	367.0M	317.0M
Gross Margin %	79.4%	79.1%	76.2%	75.1%	72.5%
Total Operating Cost	359.0M	374.0M	685.0M	432.0M	408.0M
Selling Expenses	157.0M	167.0M	156.0M	185.0M	181.0M
Admin Expenses	57.2M	55.4M	53.9M	56.8M	49.6M
Rd Expenses	36.2M	44.5M	50.5M	46.6M	34.3M
Finance Expenses	1.4M	5.3M	5.5M	6.8M	9.8M
+Operating Income	28.2M	34.0M	-292.0M	81.6M	45.0M
Operating Margin %	7.5%	8.4%	-77.5%	16.7%	10.3%
Non Operating Income	23,600	11,200	386,500	580,200	479,800
Non Operating Expenses	247,900	1.9M	928,200	81,400	567,900
Investment Income	606,200	-3.6M	-11.0M	-4.7M	-3.1M
Asset Disposal Income	32,300	924,100	28,500	332,400	-8,200
Asset Impairment Loss	17.1M	3.9M	318.0M	3.8M	5.0M
Other Income	9.6M	6.2M	26.6M	29.0M	19.0M
Income Before Tax	28.0M	32.1M	-293.0M	82.1M	44.9M
Income Tax	11.4M	11.0M	35.1M	31.3M	3.5M
+Net Income	16.6M	21.1M	-328.0M	50.7M	41.4M
Net Margin %	4.4%	5.2%	-87.0%	10.4%	9.5%
Net Income Attributable	27.4M	31.0M	-308.0M	73.7M	46.6M
Minority Interest	-10.8M	-9.9M	-19.8M	-23.0M	-5.2M
Eps Basic	0.10	0.12	-1.16	0.28	0.18
Eps Diluted	0.10	0.12	-1.16	0.28	0.18

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	107.0M	105.0M	126.0M	159.0M	156.0M
Accounts Receivable	59.5M	61.1M	72.0M	107.0M	116.0M
Notes Receivable	--	--	--	--	--
Notes And Accounts Receivable	59.5M	61.1M	72.0M	107.0M	116.0M
Prepayments	2.1M	7.2M	24.8M	11.0M	14.9M
Inventory	78.5M	71.6M	61.7M	141.0M	127.0M
Total Current Assets	266.0M	267.0M	299.0M	435.0M	438.0M
Long Term Equity Investment	4.5M	16.9M	17.4M	59.1M	66.6M
Fixed Assets	--	162.0M	183.0M	200.0M	218.0M
Fixed Assets Total	320.0M	162.0M	183.0M	200.0M	218.0M
Construction In Progress	--	74.0M	2.8M	2.4M	2.2M
Construction In Progress Total	2.5M	74.0M	2.8M	2.4M	2.2M
Intangible Assets	72.7M	78.7M	87.5M	64.1M	74.0M
Long Term Deferred Expenses	3.3M	3.7M	8.0M	15.4M	24.2M
Total Non Current Assets	489.0M	411.0M	371.0M	663.0M	697.0M
Total Assets	754.0M	679.0M	670.0M	1.1B	1.1B
Short Term Borrowings	20.0M	24.5M	49.0M	51.6M	103.0M
Accounts Payable	35.6M	29.3M	2.2M	1.9M	3.0M
Advance Receipts	720,900	--	--	--	--
Contract Liabilities	28.8M	22.0M	28.3M	17.1M	27.2M
Total Current Liabilities	178.0M	173.0M	189.0M	262.0M	303.0M
Long Term Borrowings	76.0M	12.0M	--	--	54.6M
Total Non Current Liabilities	109.0M	49.6M	50.3M	88.3M	115.0M
Total Liabilities	287.0M	222.0M	239.0M	351.0M	418.0M
Paid In Capital	265.0M	265.0M	265.0M	265.0M	265.0M
Capital Reserve	595.0M	600.0M	600.0M	598.0M	599.0M
Surplus Reserve	50.6M	47.1M	43.9M	43.9M	36.6M
Retained Earnings	-322.0M	-345.0M	-373.0M	-65.4M	-133.0M
Minority Equity	-74.8M	-64.3M	-54.4M	-35.8M	-13.6M
Equity Attributable	542.0M	521.0M	485.0M	784.0M	730.0M
Total Equity	468.0M	456.0M	431.0M	748.0M	717.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	406.0M	428.0M	445.0M	530.0M	514.0M
Tax Refunds Received	1.1M	--	--	--	4.8M
Total Operating Cash Inflow	431.0M	444.0M	463.0M	557.0M	554.0M
Cash Paid For Goods	77.3M	60.3M	59.9M	107.0M	153.0M
Cash Paid To Employees	106.0M	110.0M	118.0M	112.0M	94.6M
Taxes Paid	39.8M	46.6M	39.9M	30.8M	31.1M
Total Operating Cash Outflow	381.0M	390.0M	392.0M	435.0M	450.0M
Operating Cash Flow	49.6M	54.1M	71.0M	122.0M	104.0M
Total Investing Cash Inflow	98,600	2.8M	1.9M	16.5M	282,500
Total Investing Cash Outflow	85.0M	53.9M	41.9M	13.8M	12.9M
Investing Cash Flow	-84.9M	-51.1M	-40.0M	2.7M	-12.6M
Cash From Borrowings	85.0M	37.5M	50.0M	52.0M	158.0M
Dividends And Interest Paid	2.5M	1.2M	3.7M	7.0M	14.2M
Debt Repayments	30.8M	55.0M	107.0M	153.0M	218.0M
Total Financing Cash Inflow	85.0M	37.5M	50.0M	52.0M	158.0M
Total Financing Cash Outflow	41.4M	64.8M	121.0M	174.0M	232.0M
Financing Cash Flow	43.6M	-27.3M	-70.6M	-122.0M	-74.4M
Net Change In Cash	8.4M	-24.2M	-39.0M	3.1M	16.6M
Ending Cash Balance	104.0M	96.1M	120.0M	159.0M	156.0M
Capex	76.2M	53.9M	41.2M	4.7M	2.9M